Matthew Hamilton Rosenberg’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.9K Sell
101
-2
-2% -$171 ﹤0.01% 652
2026
Q2
$7.95K Hold
103
– – ﹤0.01% 653
2026
Q1
$6.73K Sell
103
-24
-19% -$1.78K ﹤0.01% 657
2025
Q4
$10.1K Hold
127
– – ﹤0.01% 628
2025
Q3
$9.27K Sell
127
-16
-11% -$1.17K ﹤0.01% 644
2025
Q2
$10.8K Hold
143
– – ﹤0.01% 641
2025
Q1
$10.9K Hold
143
– – ﹤0.01% 621
2024
Q4
$9.45K Sell
143
-12
-8% -$840 ﹤0.01% 629
2024
Q3
$10.8K Hold
155
– – ﹤0.01% 608
2024
Q2
$7.97K Buy
+155
New +$9.41K ﹤0.01% 619

Other funds holding SOLV

Matthew Hamilton Rosenberg's SOLV Position: Q3 2026 in Review

Matthew Hamilton Rosenberg reduced its Solventum (SOLV) stake by 1.9% in Q3 2026, selling an estimated $171 and leaving 101 shares worth $8.9K. The position accounts for ﹤0.01% of the portfolio, ranked #652.

Matthew Hamilton Rosenberg first reported a position in SOLV in Q2 2024 and has held it in 10 quarters since. The position peaked at $10.9K in Q1 2025. 31 funds tracked by Wall St. Rank hold SOLV as of Q3 2026.

  • Matthew Hamilton Rosenberg held 101 shares of Solventum worth $8.9K as of Q3 2026.
  • Matthew Hamilton Rosenberg sold 2 Solventum shares in Q3 2026, an estimated $171.
  • Solventum made up ﹤0.01% of Matthew Hamilton Rosenberg's portfolio in Q3 2026, its #652 holding.
  • Matthew Hamilton Rosenberg first reported a position in Solventum in Q2 2024 and has held it in 10 quarters since.
  • Matthew Hamilton Rosenberg's Solventum position peaked at $10.9K in Q1 2025.
  • 31 funds tracked by Wall St. Rank held Solventum as of Q3 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2026, filed 5 Oct 2026.